Coeptis Therapeutics, Inc. (COEP) Stock Analysis
DELISTED 2026
What happened to Coeptis Therapeutics, Inc. (COEP) stock?
Coeptis Therapeutics, Inc. (COEP) no longer trades on public markets. It was delisted in April 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2026
- Last recorded price (historical):
- $10.99 (last quote on record before the April 2026 delisting; historical, not a current quote)
Market cap $38.6M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Coeptis Therapeutics, Inc. (COEP). Coeptis Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing pharmaceutical products and cell therapy platforms for cancer patients.
Last analyzed: May 9, 2026Coeptis Therapeutics, Inc. (COEP) Technology Profile & Competitive Position
More about this archive record
Can I still buy COEP shares?
No. COEP stopped trading on public markets in April 2026, so the shares are not available through a broker. Anything you see quoted for COEP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before COEP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Coeptis Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.